Abstract
Activity of the telomerase catalytic subunit hTERT (human Telomerase Reverse Transcriptase) can be regulated by alternative splicing of its mRNA. At the present time, the exact mechanism of hTERT splicing is not fully understood. Apoptotic endonuclease EndoG is known to participate this process. EndoG expression is induced by DNA damages. The aim of this work was to investigate the ability of DNA-damaging agents with different mechanism of action to induce EndoG expression and to inhibit telomerase activity due to the activation of hTERT alternative splicing in normal activated human CD4+ and CD8+ Т lymphocytes. All investigated DNA-damaging agents were able to induce EndoG expression. Cisplatin, a therapeutic compound, producing DNA cross-links induced the highest level of DNA damages and EndoG expression. Incubation of CD4+ and CD8+ Т cells with cisplatin caused the changes in proportion of hTERT splice variants and inhibition of telomerase activity.
Similar content being viewed by others
References
Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L., and Shay, J.W., Science, 1994, vol. 266, pp. 2011–2015.
Saeboe-Larssen, S., Fossberg, E., and Gaudernack, G., BMC Mol. Biol., 2006, vol. 7, 26.
Ulaner, G.A., Hu, J.F., Vu, T.H., Oruganti, H., Giudice, L.C., and Hoffman, A.R., Int. J. Cancer, 2000, vol. 85, pp. 330–335.
Ulaner, G.A., Hu, J.F., Vu, T.H., Giudice, L.C., and Hoffman, A.R., Cancer Res., 1998, vol. 58, pp. 4168–4172.
Zhdanov, D.D., Vasina, D.A., Orlova, E.V., Orlova, V.S., Pokrovskaya, M.V., Aleksandrova, S.S., and Sokolov, N.N., Biomed. Khim., 2016, vol. 62, pp. 544–554. doi 10.18097/PBMC20166205544
Zhdanov, D.D., Vasina, D.A., Orlova, V.S., Gotovtseva, V.Y., Bibikova, M.V., Pokrovsky, V.S., Pokrovskaya, M.V., Aleksandrova, S.S., and Sokolov, N.N., Biomed. Khim., 2016, vol. 62, pp. 239–250. doi 10.18097/PBMC20166203239
Yin, X., Apostolov, E.O., Shah, S.V., Wang, X., Bogdanov, K.V., Buzder, T., and Stewart, A.G., J. Am. Soc. Nephrol., 2007, vol. 18, pp. 2544–2553.
Zhdanov, D.D., Vasina, D.A., Orlova, E.V., Orlova, V.S., Pokrovsky, V.S., Pokrovskaya, M.V., Aleksandrova, S.S., and Sokolov, N.N., Biomed. Khim., 2017, vol. 63, pp. 13–26. doi 10.18097/PBMC20176301013
Chan, F.K.-M., Moriwaki, K., and De Rosa, M.J., Methods Mol. Biol., 2013, vol. 979, pp. 65–70.
Darzynkiewicz, Z., Galkowski, D., and Zhao, H., Methods, 2008, vol. 44, pp. 250–254.
Yang, W., FEBS Lett., 2005, vol. 579, pp. 868–872.
Ling, H., Sayer, J.M., Plosky, B.S., Yagi, H., Boudsocq, F., Woodgate, R., Jerina, D.M., and Yang, W., Proc. Natl. Acad. Sci. USA, 2004, vol. 101, pp. 2265–2269.
Mira, A., Gimenez, E.M., Bolzan, A.D., Bianchi, M.S., and Lopez-Larraza, D.M., Arch. Environ. Occup. Health., 2013, vol. 68, pp. 107–116.
Povirk, L.F. and Finley Austin, M.J., Mutat. Res. Genet. Toxicol., 1991, vol. 257, pp. 127–143.
Kuefner, M.A., Brand, M., Engert, C., Schwab, S.A., and Uder, M., Rofo, 2015, vol. 187, pp. 872–878.
Perez, R.P., Eur. J. Cancer, 1998, vol. 34, pp. 1535–1542.
McGill, M., Pathak, S., and Hsu, T.C., Chromosoma, 1971, vol. 47, pp. 157–166.
Ikeuchi, T., Cytogenet. Cell Genet., 1984, vol. 38, pp. 56–61.
Ruiz-Carrillo, A. and Renaud, J., EMBO J., 1987, vol. 6, pp. 401–407.
Zhdanov, D.D., Fahmi, T., Wang, X., Apostolov, E.O., Sokolov, N.N., Javadov, S., and Basnakian, A.G., DNA Cell Biol., 2015, vol. 34, pp. 316–326.
Listerman, I., Sun, J., Gazzaniga, F.S., Lukas, J.L., and Blackburn, E.H., Cancer Res., 2013, vol. 73, pp. 2817–2828.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © D.D. Zhdanov, D.A. Vasina, V.S. Orlova, E.V. Orlova, D.V. Grishin, Y.A. Gladilina, M.V. Pokrovskaya, S.S. Aleksandrova, N.N. Sokolov, 2018, published in Biomeditsinskaya Khimiya.
The article was translated by the author (D.D. Zhdanov).
Rights and permissions
About this article
Cite this article
Zhdanov, D.D., Vasina, D.A., Orlova, V.S. et al. Induction of Apoptotic Endonuclease EndoG with DNA-Damaging Agents Initiates Alternative Splicing of Telomerase Catalytic Subunit hTERT and Inhibition of Telomerase Activity hTERT in Human CD4+ and CD8+ Т Lymphocytes. Biochem. Moscow Suppl. Ser. B 12, 119–129 (2018). https://doi.org/10.1134/S1990750818020154
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750818020154